Clinical Trial Update: Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nab-paclitaxel in combination with gemcitabine in Chinese patients with advanced pancreatic cancer. The status is not disclose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN